Results 191 to 200 of about 58,334 (260)

Current Evidence on Celecoxib Safety in the Management of Chronic Musculoskeletal Conditions: An Umbrella Review. [PDF]

Drugs
Beaudart C, Brabant C, Alokail M, Reginster JY, Bruyère O.   +4 more
europepmc   +1 more source

Antiproliferative Effects of Celecoxib in Hep-2 Cells through Telomerase Inhibition and Induction of Apoptosis

, 2014
Yongqiang Zhao, Hui‐Wei Feng, Tao Jia, Xuemei Chen, Hui Zhang, Anting Xu, Hailing Zhang, Xian-Liang Fan   +7 more
openalex   +2 more sources

Correction: Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells. [PDF]

PLoS One
Cervello M, Bachvarov D, Lampiasi N, Cusimano A, Azzolina A, McCubrey JA, Montalto G.   +6 more
europepmc   +1 more source

Lenalidomide, celecoxib, and azacitidine therapy for blastic plasmocytoid dendritic cell neoplasm: a case report

, 2016
Antonio Gutiérrez, Marta García‐Recio, Jordi Martínez-Serra, Leyre Bento, R. Asensio, Jordi Ginés, Jaime Daumal, Antònia Sampol   +7 more
openalex   +2 more sources

A systematic review and meta-analysis of the effect of acupuncture therapy on the symptoms and immune indicators of ankylosing spondylitis. [PDF]

Front Neurol
Wang Y, Zhu J, Xue F, Liu W.
europepmc   +1 more source

In vitro celecoxib supplementation impacts the functional capacities of the gut microbiota [PDF]

, 2017
Calatayud Arroyo, Marta, Heiremans, Evelien, Hernandez Sanabria, Emma, Leclercq, Laurent, Mangelinckx, Sven, Roman, Bart, Snoeys, Jan, Van de Wiele, Tom   +7 more
core   +1 more source

Patient-reported improvements from use of IMC-2 alone and IMC-2 and Paxlovid^® in a Long COVID cohort: a case series. [PDF]

Front Immunol
Pridgen WL, Putrino D.
europepmc   +1 more source

Individualizing NSAID therapy in axial spondyloarthritis: N-of-1 trials with Bayesian analysis. [PDF]

Rheumatology (Oxford)
Hwang MC, Kim S, Assassi S, Chavez R, Samuel J, Green C, Tyson J, Reveille J.   +7 more
europepmc   +1 more source

Prophylactic effects of non-steroidal anti-inflammatory drugs on heterotopic ossification after total hip arthroplasty: a Bayesian network meta-analysis of randomized controlled trials using cumulative logistic regression. [PDF]

BMC Musculoskelet Disord
Xie L, Li Z, Huang Y, Du X, Chen X.
europepmc   +1 more source